• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Technology
    • AI
    • History of Otolaryngology
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
    • SUO Corner
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Precision Medicine Strategies in Otolaryngology

by Karen Appold • January 7, 2019

  • Tweet
  • Email a link to a friend (Opens in new window) Email
Print-Friendly Version

Applications beyond Cancer

© VectorPot / shutterstock.com

© VectorPot / shutterstock.com

Analysis of patient genomes may also improve the treatment of many congenital anomalies, syndromes, and hearing and balance disorders caused by genetic alterations. Furthermore, with recent breakthroughs in gene-editing technology, including the use of CRISPR-Cas9 gene editing, Dr. Mandal said it may one day be possible to target these mutations in germline cells.

You Might Also Like

  • A Look at the Status of Precision Diagnostic Techniques in Otolaryngology
  • How Otolaryngologists Can Apply Predictive Medicine to Patient Care
  • Gene Therapy: A Promising Role in Otolaryngology
  • Evidence-Based Medicine Comes to Otolaryngology
Explore This Issue
January 2019

Dr. Bleier said the future of precision medicine is in developing noninvasive biosignatures from patients. “By doing this, we can sample them over time prospectively and repeatedly without causing trauma,” he said. “This will allow a physician to make a diagnosis upfront and then track how a patient’s disease evolves and responds to treatment.”

Precision medicine might also fuel efforts to identify the microbiome of the oral cavity and sinuses as a factor in chronic inflammatory conditions such as sinusitis, and evaluate its importance in explaining the individual’s susceptibility to transition from acute to chronic disease. A research group at Dr. Wang’s institution is currently studying this possibility.

Dr. Yates said that a better understanding of the genomic influences on foods, drugs, environmental effects, lifestyle choices, noise exposure, and a host of other factors may ultimately prevent problems, although this type of research is in the early stage.

Hinrich Staecker, MD, PhD, professor of otolaryngology-head and neck surgery at the University of Kansas School of Medicine in Kansas City, said treatment of sensorineural hearing loss will be significantly improved through developing biomarkers for different types of sensorineural loss. Currently, serum-based biomarkers for diverse disorders such as noise-induced hearing loss and benign paroxysmal positional vertigo are being developed. Studies identifying subtypes of Meniere’s disease are underway. “Based on these studies, we will develop pharmacotherapy and molecular therapy targeting for different types of sensorineural hearing loss,” he said.

Dr. Roehm said techniques involved in precision medicine, which couples databank searches of large amounts of patient information with NGS and other genomic evaluations of patients, could potentially identify more genes and genetic loci involved in hearing loss and aid in its treatment, as noted in a recently published study (J Genet Genomics. 2018;45(2):99-109). “Personalized patient knowledge of their genetic makeup could potentially assist in avoiding the development of hearing loss,” she said. For example, factors that predispose to ototoxic hearing loss, such as deletions in the Sod1 superoxide dismutase gene, have been identified. Physicians could inform patients with this mutation to avoid exposure to aminoglycosides due to their increased risk of hearing loss from these antibiotics.

In the future, genetic treatments specific to an identified defect will likely help to target mutations, enabling the application of highly individualized treatment approaches. Precision medicine will also likely further subclassify sensorineural hearing loss. “This could be critical in various aspects of patient management, but especially in candidacy selection for cochlear implantation,” Dr. Adunka said. “Specifically, the success or failure of hearing preservation will likely match a patient’s genetic profile obtained through precision medicine testing.”

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Features Tagged With: precision medicineIssue: January 2019

You Might Also Like:

  • A Look at the Status of Precision Diagnostic Techniques in Otolaryngology
  • How Otolaryngologists Can Apply Predictive Medicine to Patient Care
  • Gene Therapy: A Promising Role in Otolaryngology
  • Evidence-Based Medicine Comes to Otolaryngology

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Have you ever worked with industry on a product, device, technique, or medication to improve the ENT specialty?

View Results

Loading ...
  • Polls Archive

Top Articles for Residents

  • Rhinology’s Persistent Gender Gap
  • The Example We Set: Thoughts on the End of Residency Training
  • Is the SLOR in Otolaryngology Residency Applications Contributing to Rural Disparities?
  • Applications Open for Resident Members of the ENTtoday Editorial Board: Deadline Extended
  • A Resident’s View of AI in Otolaryngology
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • History of the Cochlear Implant
    • Empty Nose Syndrome: Physiological, Psychological, or Perhaps a Little of Both?
    • The Unspoken Load: Why Walking into the Exam Room Has Never Been Harder
    • When a “Blocked Ear” Isn’t Obstructive ETD
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?
    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?
    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment
    • History of the Cochlear Implant
    • ENT Surgeons Working with Industry
    • What an Extraordinary Time to Be an Otolaryngologist
    • Outcomes of Pediatric Prophylactic Thyroidectomy in MEN2: A Systematic Review
    • Blue-Laser Posterior Nasal Neurolysis via Dual-Layer Nerve Modulation for Chronic Rhinitis
    • Hypoglossal Nerve Stimulation and the Incidence of Cardiovascular Disease

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2026 by The Triological Society. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939